REFERENCES
- Pitman S W, Frei E, III. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep. 1977; 61: 695–701, [PUBMED], [INFOTRIEVE], [CSA]
- Ahmad S, Shen F H, Bleyer W A. Methotrexate-induced renal failure and ineffectiveness of peritoneal dialysis. Arch Intern Med. 1978; 138: 1146–1147, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bouffet E, Frappaz D, Laville M. Charcoal haemoperfusion and methotrexate toxicity. Lancet. 1986; 1: 1497, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Widemann B C, Balis F M, Kempf-Bielack B. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma: incidence, treatment, and outcome. Cancer. 2004; 100: 2222–2232, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- International Berlin–Frankfurt–Muenster Study Group. ALL IC-BFM 2002: a randomised trial of the I-BFM-SG for the management of childhood non-B acute lymphoblastic leukemia. I-BFM-SG, Hannover 2002
- Perazella M A. Crystal-induced acute renal failure. Am J Med. 1999; 106: 459–465, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Jacobs S A, Stoller R G, Chabner B A, Johns D G. 7-Hydroxymethotrexate as a urinary metabolite in human subjects and Rhesus monkeys receiving high dose methotrexate. J Clin Invest. 1976; 57: 534–538, [PUBMED], [INFOTRIEVE], [CSA]
- Rubnitz J E, Relling M V, Harrison P L. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia. 1998; 12: 1176–1181, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bernini J C, Fort D W, Griener J C, Kane B J, Chappell W B, Kamen B A. Aminophylline for methotrexate-induced neurotoxicity. Lancet. 1995; 345: 544–547, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Peyriere H, Poiree M, Cociglio M, Margueritte G, Hansel S, Hillaire-Buys D. Reversal of neurologic disturbances related to high-dose methotrexate by aminophylline. Med Pediatr Oncol. 2001; 36: 662–664, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Widemann B C, Hetherington M L, Murphy R F, Balis F M, Adamson P C. Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity. Cancer. 1995; 76: 521–526, [PUBMED], [INFOTRIEVE], [CSA]
- Thierry F X, Vernier I, Dueymes J M. Acute renal failure after high-dose methotrexate therapy: role of hemodialysis and plasma exchange in methotrexate removal. Nephron. 1989; 51: 416–417, [PUBMED], [INFOTRIEVE], [CSA]
- Kawabata K, Makino H, Nagake Y. A case of methotrexate-induced acute renal failure successfully treated with plasma perfusion and sequential hemodialysis. Nephron 1995; 71: 233–234, [PUBMED], [INFOTRIEVE], [CSA]
- Krackhardt A, Schwartz S, Korfel A, Thiel E. Carboxypeptidase G2 resuce in a 79-year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure. Leukemia Lymph. 1999; 35: 631–635, [CSA]
- van den Bongard H J, Mathot R A, Boogerd W. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure. Cancer Chemother Pharmacol. 2001; 47: 237–240, [CROSSREF], [CSA]
- Greil J, Wyss P A, Ludwig K. Continuous plasma resin perfusion for detoxification of methotrexate. Eur J Pediatr. 1997; 156: 933–936, [CROSSREF], [CSA]
- Kepka L, de Lassence A, Ribrag V. Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leukemia Lymph. 1998; 29: 205–209, [CSA]
- Maiche A G. Acute renal failure due to concomitant action of methotrexate and indomethacin. Lancet. 1986; 1: 1390, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Peyriere H, Cociglio M, Margueritte G, Vallat C, Blayac J P, Hillaire-Buys D. Optimal management of methotrexate intoxication in a child with osteosarcoma. Ann Pharmacother. 2004; 36: 422–427, [CSA]
- Maiche A G, Lappalainen K, Teerenhovi L. Renal insufficiency in patients treated with high dose methotrexate. Acta Oncol. 1988; 27: 73–74, [PUBMED], [INFOTRIEVE], [CSA]
- Crews K R, Liu T, Rodriguez-Galindo C. High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer. 2004; 100: 1724–1733, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Quader M A, Sawmiller C, Sumpio B A. Contrast-induced nephropathy: review of incidence and pathophysiology. Ann Vasc Surg. 1998; 12: 612–620, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Haight A E, Kaste S C, Goloubeva O G, Xiong X P, Bowman L C. Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation. Radiology. 2003; 226: 399–404, [PUBMED], [INFOTRIEVE], [CSA]
- Buchen S, Ngampolo D, Melton R G. Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. Br J Cancer. 2005; 92: 480–487, [PUBMED], [INFOTRIEVE], [CSA]